
NMR · NYSE
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $1.20T | $1.07T | $896.49B | $707.94B | $790.79B | $759.86B | $700.13B | $694.39B |
| Income Before Taxes | $539.82B | $471.96B | $273.85B | $149.47B | $226.62B | $230.67B | $248.26B | -$37.70B |
| Basic Shares Outstanding | 2942.28T | 2955.20T | 3017.13T | 3006.74T | 3063.52T | 3055.53T | 3202.37T | 3359.56T |
| Diluted Shares Outstanding | 3041.19T | 3066.46T | 3144.54T | 3114.31T | 3158.71T | 3147.34T | 3276.51T | 3359.57T |
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| Mar 2027 | $0.93 | $0.93 | $0.93 | 1 | ↑1 ↓0 |
| Mar 2028 | $0.95 | $0.95 | $0.95 | 1 | ↑1 ↓0 |